Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital

Pediatric Infectious Disease Journal

Volumn 27, Issue 2, 2008, Pages 106-111

  Metjian, Talene A ^a   Prasad, Priya A ^a   Kogon, Amy ^a   Coffin, Susan E ^a,b   Zaoutis, Theoklis E ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antimicrobials; Interventions; Pediatric; Stewardship

Indexed keywords

ACICLOVIR; AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B LIPID COMPLEX; ANTIINFECTIVE AGENT; AZITHROMYCIN; AZTREONAM; CASPOFUNGIN; CEFDINIR; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIDOFOVIR; CIPROFLOXACIN; CLARITHROMYCIN; FLUCONAZOLE; GANCICLOVIR; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; OSELTAMIVIR; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN; UNINDEXED DRUG; VANCOMYCIN; VORICONAZOLE;

ANTIBIOTIC THERAPY; ARTICLE; CONSULTATION; DRUG INDICATION; DRUG USE; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL METHOD; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; TEACHING HOSPITAL; CLINICAL PRACTICE; HEALTH CARE QUALITY; HOSPITAL; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE;

ANTI-BACTERIAL AGENTS; DRUG UTILIZATION REVIEW; HOSPITALS, PEDIATRIC; HOSPITALS, TEACHING; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PROGRAM EVALUATION; PROSPECTIVE STUDIES;

EID: 40949097417     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318158603a     Document Type: Article

References (38)

1. Scheckler WE, Bennett JV. Antibiotic usage in seven community hospitals. JAMA. 1970;213:264-267.
2. Roberts AW, Visconti JA. The rational and irrational use of systemic antimicrobial drugs. Am J Hosp Pharm. 1972;29:828-834.
3. Reimann HA. The misuse of antimicrobics. Med Clin North Am. 1961; 45:849-856.
4. Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis. 1988;157:869-876.
5. Kislak JW, Eickhoff TC, Finland M. Hospital-acquired infections and antibiotic usage in the Boston City Hospital-January, 1964. N Engl JMed. 1964;271:834-835.
6. John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997;24:471-485.
7. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin- resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53-59.
8. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003;36:1433-1437.
9. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):S82-S89.
10. McGowan JE Jr. Economic impact of antimicrobial resistance. Emerg Infect Dis. 2001;7:286-292.
11. Shlaes DM, Gerding DN, John JF Jr, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997;25:584-599.
12. Schentag JJ, Ballow CH, Fritz AL, et al. Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory. Diagn Microbiol Infect Dis. 1993;16:255-264.
13. Ruttimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis. 2004;38:348-356.
14. Lutters M, Harbarth S, Janssens JP, et al. Effect of a comprehensive, multidisciplinary, educational program on the use of antibiotics in a geriatric university hospital. J Am Geriatr Soc. 2004;52:112-116.
15. Carling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003;24:699-706.
16. LaRocco A Jr. Concurrent antibiotic review programs-a role for infectious diseases specialists at small community hospitals. Clin Infect Dis. 2003;37:742-743.
17. Ansari F, Gray K, Nathwani D, et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother.2003;52:842-848.
18. Sunenshine RH, Liedtke LA, Jernigan DB, et al. Role of infectious diseases consultants in management of antimicrobial use in hospitals. Clin Infect Dis. 2004;38:934-938.
19. Barlam TF, DiVall M. Antibiotic-stewardship practices at top academic centers throughout the United States and at hospitals throughout Massachusetts. Infect Control Hosp Epidemiol. 2006;27:695-703.
20. American Academy of Pediatrics. Subcommittee on Management of Acute Otitis Media. Clinical practice guideline: diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451-1465.
21. American Academy of Pediatrics. Subcommittee on management of sinusitis and committee on quality improvement. Clinical practice guideline: management of sinusitis. Pediatrics. 2001;108:798 -808.
22. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on urinary tract infection. Pediatrics. 1999; 103(4 Pt 1):843-852.
23. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267-1284.
24. Nageswaran S, Woods CR, Benjamin DK Jr, Givner LB, Shetty AK. Orbital cellulitis in children. Pediatr Infect Dis J. 2006;25:695-699.
25. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32: 1249-1272.
26. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27-S72.
27. Kaplan SL. Osteomyelitis in children. Infect Dis Clin North Am. 2005; 19:787-797, vii.
28. Pediatrics AAP. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006.
29. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997; 111:676-685.
30. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med. 1998;244:379-386.
31. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462-474.
32. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146-155.
33. Rello J, Gallego M, Mariscal D, Soñora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156:196-200.
34. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU- Acquired Pneumonia Study Group. Intensive Care Med. 1996;22: 387-394.
35. Glowacki RC, Schwartz DN, Itokazu GS, Wisniewski MF, Kieszkowski P, Weinstein RA. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin Infect Dis. 2003;37:59-64.
36. Briceland LL, Nightingale CH, Quintiliani R Cooper BW, Smith KS. Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach. Arch Intern Med. 1988;148:2019-2022.
37. White AC Jr, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis. 1997;25:230-239.
38. Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis. 2001;33:289-295.